A novel management program for hypertension

Chun-Song Hu; Ya-Ling Han; Jun-Bo Ge; Qing-Hua Wu; Yan-Na Liu; Chang-Sheng Ma; Tengiz Tkebuchava; Da-Yi Hu

doi:10.3978/j.issn.2223-3652.2015.05.13

A novel management program for hypertension

Cardiovasc Diagn Ther. 2015 Aug;5(4):316-22. doi: 10.3978/j.issn.2223-3652.2015.05.13.

Authors

Chun-Song Hu¹, Ya-Ling Han¹, Jun-Bo Ge¹, Qing-Hua Wu¹, Yan-Na Liu¹, Chang-Sheng Ma¹, Tengiz Tkebuchava¹, Da-Yi Hu¹

Affiliation

¹ 1 Department of Cardiology, Nanchang University, Nanchang 330006, China ; 2 Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang 110840, China ; 3 Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China ; 4 Department of Cardiology, Center for Atrial Fibrillation, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China ; 5 Boston TransTec, LLC, MA 02459, USA ; 6 Cardiovascular Center, Peking University People's Hospital, Beijing 100044, China.

PMID: 26331115
PMCID: PMC4536474
DOI: 10.3978/j.issn.2223-3652.2015.05.13

Abstract

In this article, we describe a comprehensive management program for hypertension (HTN), based on the experience of leading cardiovascular centers in China. This comprehensive approach, adhering to a number of core principles, includes diagnosis and therapeutic interventions. Therapeutic management includes lifestyle changes, risk factor management and pharmacological intervention and should allow reliable lowering blood pressure (BP). Additional paragraphs discuss the relationship between paroxysmal atrial fibrillation (PAF), and HTN.

Keywords: Hypertension (HTN); paroxysmal atrial fibrillation (PAF); treatment.